Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

306
Actual shortage: 11 (4%)
Anticipated shortage: 7 (2%)
Avoided shortage: 25 (8%)
Resolved: 263 (86%)

Discontinuation Reports

1
To be discontinued: 0 (0%)
Discontinued: 1 (100%)
Reversed: 0 (0%)

Late reports

90 (29%)

Overdue reports

1 (6%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EDARBYCLOR 12.5MG 40MG TABLET Avoided shortage 2019-05-08 2019-05-23 83479
XERESE 1% 5% CREAM Avoided shortage 2023-02-08 2023-04-11 183894
LODALIS 3.75G POWDER FOR SUSPENSION Avoided shortage 2022-06-29 2022-08-03 163659
MESTINON 60MG TABLET Resolved 2019-06-21 2019-07-24 87189
MESTINON-SR 180MG TABLET (EXTENDED-RELEASE) Resolved 2018-04-06 2018-04-13 45130
RETIN-A 0.05% CREAM Resolved 2017-08-17 2018-03-30 19739
RETIN-A 0.05% CREAM Resolved 2021-04-21 2021-05-19 137879
RETIN-A 0.025% GEL Resolved 2018-04-06 2018-06-20 45139
RETIN-A 0.025% GEL Resolved 2019-03-22 2019-09-10 79311
RETIN-A 0.025% GEL Resolved 2021-08-26 2021-11-10 144618
RETIN-A 0.025% GEL Resolved 2022-09-23 2022-09-28 170140
DELATESTRYL 200MG SOLUTION Resolved 2017-06-16 2017-06-24 12960
DELATESTRYL 200MG SOLUTION Resolved 2017-09-25 2018-01-23 23236
DELATESTRYL 200MG SOLUTION Resolved 2018-11-09 2019-01-11 66583
DELATESTRYL 200MG SOLUTION Resolved 2019-11-13 2020-01-09 98649
DELATESTRYL 200MG SOLUTION Resolved 2020-05-28 2020-09-30 116048
DELATESTRYL 200MG SOLUTION Resolved 2021-02-26 2021-09-13 134792
DELATESTRYL 200MG SOLUTION Resolved 2022-12-02 2022-12-21 176956
DELATESTRYL 200MG SOLUTION Resolved 2023-01-18 2023-04-22 181436
DELATESTRYL 200MG SOLUTION Resolved 2023-05-04 2023-05-31 191622

Showing 41 to 60 of 306

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
THEOLAIR 80MG SOLUTION Discontinued 2021-04-26 2021-04-27 138081

Showing 1 to 1 of 1